- Investing Ideas
- /
- U.K. Pharmaceuticals & Biotech Potentially Undervalued Companies
U.K. Pharmaceuticals & Biotech Potentially Undervalued Companies
Results
233
Companies with a Value score of at least 3, ordered by Value score
233 companies
Danaher
Market Cap: US$138.1b
Designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally.
0R2B
US$192.38
7D
8.1%
1Y
-20.2%
Bonesupport Holding
Market Cap: SEK 20.4b
An orthobiologics company, develops and commercializes injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally.
0RQO
SEK 303.77
7D
0.7%
1Y
27.5%
Alnylam Pharmaceuticals
Market Cap: US$31.1b
Alnylam Pharmaceuticals, Inc. discovers, develops, and commercializes therapeutics based on ribonucleic acid interference.
0HD2
US$237.47
7D
2.0%
1Y
61.1%
Camurus
Market Cap: SEK 33.0b
A biopharmaceutical company, develops and commercializes medicines for severe and chronic conditions in Europe, Australia, the United States, and internationally.
CAMXS
SEK 572.00
7D
0%
1Y
n/a
Vitrolife
Market Cap: SEK 21.1b
Provides assisted reproduction products in Europe, the Middle East, Africa, Asia-Pacific, and the Americas.
VITRS
SEK 174.25
7D
0%
1Y
-7.9%
argenx
Market Cap: €32.2b
A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.
ARGXB
€521.30
7D
0%
1Y
45.7%
Madrigal Pharmaceuticals
Market Cap: US$7.0b
A biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States.
0JXI
US$326.03
7D
3.4%
1Y
36.5%
Basilea Pharmaceutica
Market Cap: CHF 497.9m
Engages in the discovering, developing, and commercializing drugs for bacterial or fungal infections.
BSLNz
CHF 41.08
7D
3.3%
1Y
0.7%
Haleon
Market Cap: UK£34.2b
Engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific.
HLN
UK£3.79
7D
6.3%
1Y
17.1%
Genfit
Market Cap: €155.0m
A late-stage biopharmaceutical company, discovers and develops drug candidates and diagnostic solutions for metabolic and liver-related diseases.
0QT6
€3.07
7D
3.6%
1Y
-6.2%
Siegfried Holding
Market Cap: CHF 3.8b
Engages in contract development and manufacturing of active pharmaceutical ingredient (API) and finished dosage forms worldwide.
SFZNZ
CHF 863.00
7D
5.6%
1Y
-3.1%
Tissue Regenix Group
Market Cap: UK£26.0m
A medical technology company, develops and commercializes platform technologies in the field of bone graft substitutes and soft tissue in the United States and internationally.
TRX
UK£0.36
7D
5.8%
1Y
-40.7%
Galderma Group
Market Cap: CHF 18.7b
Operates as a dermatology company worldwide.
GALDZ
CHF 79.00
7D
0.8%
1Y
24.4%
Blueprint Medicines
Market Cap: US$5.3b
A precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally.
0HOJ
US$80.91
7D
1.4%
1Y
-6.6%
Equillium
Market Cap: US$17.3m
A clinical-stage biotechnology company, develops therapeutics to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need in the United States.
0A4D
US$0.48
7D
5.4%
1Y
-73.1%
Atara Biotherapeutics
Market Cap: US$34.3m
Engages in the development of transformative therapies for patients with cancer and autoimmune disease in the United States and the United Kingdom.
0HIY
US$5.56
7D
-2.5%
1Y
-67.2%
10x Genomics
Market Cap: US$1.0b
A life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in the Americas, Europe, the Middle East, Africa, China, and the Asia Pacific.
0A88
US$8.30
7D
15.0%
1Y
-73.2%